Scinovex
Subscribe
Health Sciences → Medicine → Pulmonary and Respiratory Medicine

Advanced Breast Cancer Therapies

This cluster of papers focuses on the use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as palbociclib, letrozole, ribociclib, and abemaciclib, in the treatment of hormone receptor-positive metastatic breast cancer. The papers cover various aspects including clinical trials, mechanisms of action, therapeutic resistance, combination strategies, and potential biomarkers.

35.7K works worldwide243.6K citations
CDK4/6 InhibitorsBreast CancerPalbociclibLetrozoleRibociclibAbemaciclibHormone Receptor-PositiveMetastatic Breast CancerCell Cycle ControlTherapeutic Resistance

Journals publishing in this area

Articles on Scinovex in this research area

1 articles, most cited first

  1. The contribution of cell cycle dysregulation to metastasis and cancer recurrence
    International Journal of Biology Sciences · 2023 · 0 citations · AI summary